Home › NDC Lookup › RxCUI directory › RxCUI 352091

Simethicone 180 MG Oral Capsule [Phazyme] — RxCUI 352091

RxNorm drug concept · Semantic branded drug
RxCUI 352091 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI352091
Official nameSimethicone 180 MG Oral Capsule [Phazyme]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPhazyme 180 MG Oral Capsule; PhaZyme Ultra Strength 180 MG Oral Capsule
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Simethicone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Simethicone works to relieve the uncomfortable pressure, bloating, and full or stuffed feeling that comes from trapped gas in your stomach or intestines. It's used when gas builds...
  • What exactly does simethicone do for gas?
  • Yes — there are infant-specific simethicone products, like Mylicon Infants Gas Relief and similar infant drops, designed just for babies. They're used to relieve gas discomfort tha...
  • Can I give simethicone drops to my baby?
📖 Read our full Simethicone guide →

🕸️ Concept Web — How Simethicone 180 MG Oral Capsule [Phazyme] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Simethicone 180 MG Oral Capsule [Phazyme] RxCUI 352091

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Simethicone 9796
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Phazyme 219191
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Simethicone Oral Capsule 373880
    • Simethicone Oral Product 1158751
    • Simethicone Pill 1158752
    • Simethicone Oral Capsule [Phazyme] 1537488
    • Phazyme Oral Product 1178881
    • Phazyme Pill 1178882
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Simethicone 180 MG Oral Capsule SCD · 252294
  • Simethicone 180 MG SCDC · 334383
  • Simethicone Oral Capsule SCDF · 373880
  • Simethicone Oral Product SCDG · 1158751
  • Simethicone Pill SCDG · 1158752

Brand-Name Concepts

  • Simethicone 180 MG [Phazyme] SBDC · 575835
  • Simethicone Oral Capsule [Phazyme] SBDF · 1537488
  • Phazyme Oral Product SBDG · 1178881
  • Phazyme Pill SBDG · 1178882
  • Phazyme BN · 219191

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 352091 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00132-0208-12 1 BLISTER PACK in 1 BOX (0132-0208-12) / 12 CAPSULE, GELATI... PHAZYME C.B. Fleet Company, Inc. 2012-02-01
00132-0208-84 1 BOTTLE in 1 BOX (0132-0208-84) / 48 CAPSULE, GELATIN COAT... PHAZYME C.B. Fleet Company, Inc. 2012-02-01
Observed labelers: C.B. Fleet Company, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.